Skip to content

Clinical trials

Terminated Papillomavirus Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Papillomavirus Infections Status: Terminated Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20081
20102
20111
20131
20161
20171
20184
20192
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
National Cancer Institute (NCI)2
Takeda2
Antiva Biosciences1
Centre Hospitalier Régional d'Orléans1
Gilead Sciences1
Janssen Vaccines & Prevention B.V.1
M.D. Anderson Cancer Center1
McGill University1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Papillomavirus Infections17
Squamous Cell Carcinoma of Head and Neck4
Uterine Cervical Dysplasia3
Oropharyngeal Neoplasms2
Uterine Cervical Neoplasms2
Abortion, Spontaneous1
Anus Neoplasms1
Atypical Squamous Cells of the Cervix1
HIV Infections1
Nasopharyngeal Neoplasms1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.